Provided by Getty Image Bank
According to the pharmaceutical and bio industry on the 21st, Pfizer Pharmaceuticals Korea is in the process of applying for a formal item permission to the Ministry of Food and Drug Safety within this month.
However, since AstraZeneca’s Corona 19 vaccine is already being reviewed by the Ministry of Food and Drug Safety, we are not sure which product will be approved first.
An official from Pfizer Pharm drew a line saying,’We are working hard to apply for a corona 19 vaccine item license with the KFDA as quickly as possible, but it is difficult to mention a clear date.
Pfizer’s Corona 19 vaccine is known as the first product to be brought in through the COVAX facility, an international project for joint purchase and distribution of vaccines, so there is high expectation that the related process will proceed quickly.
However, there is a condition that the Pfizer vaccine must be distributed through a’cold chain’ at cryogenic temperatures below -70℃. In order to introduce it into Korea, a system that can distribute and store vaccines in cryogenic conditions must be established in advance.
Currently, according to the Ministry of Food and Drug Safety, AstraZeneca is conducting a review of approval for the Corona 19 vaccine, and a preliminary review of data related to clinical trials of Pfizer and Janssen’s Corona 19 vaccine.
Although the initial quantity of corona vaccine and the diversity of manufacturers are limited, it is necessary to implement vaccination by referring to overseas side effects cases and effects.
For this reason, the government announced that it will be vaccinated against Corona 19 from February, but attention was focused on who could get the Corona 19 vaccine first.
According to the Central Defense Response Headquarters, considering the limitations of the amount of vaccinations, a number of serious cases of serious illness in the elderly, and the high burden of the medical community for the treatment of critically ill patients, it is considered to focus on high-risk groups in nursing hospitals or nursing facilities. He said he was doing.
Therefore, the’Priority Vaccination Recommendation Targets’ released by the Central Defense Response Headquarters on the 11th include medical institution workers, group facility residents and workers, the elderly (65 years or older), adults with chronic diseases, children and adolescents education and childcare facility workers and employees, and coronavirus. 19 First responders, adults aged 50-64, police, firefighting officials, soldiers, prisoners and staff at correctional facilities and treatment centers were included. The order does not imply priority.